Time recall; future concept of chronomodulating chemotherapy for cancer

Paul Zarogoulidis, Kaid Darwiche, Haidong Huang, Dionysis Spyratos, Lonny Yarmus, Qiang Li, Stylianos Kakolyris, Konstantinos Syrigos, Konstantinos Zarogoulidis

Research output: Contribution to journalArticle

Abstract

The human metabolism is regulated by our internal clock; the circadian rhythm (24h-25h). There are several factors included in the regulatory pathway such as; genes (PER1-3), (CRY1-2), TIM hormones (cortisol, catecholamines, melatonin and insulin) drugs, enzymes, sleep disorders and diseases. Each one contributes in a different degree and in order to enhance the therapeutic result; we should include these factors into clusters instead of targeting each factor one by one. Malignances deregulate gene-protein expression/production, enzyme production, and in addition they induce fatigue, insomnia, stress and sleep disorders. All these factors finally contribute in minimizing the efficiency of chemotherapy treatment and quality of life. In addition, the circadian rhythm disruption induces tumor genesis, stress, and downregulates the defense and repair mechanisms of the human body. In the current mini review the underlying mechanism of the circadian rhythm is provided, along with the influence of sleep disturbances in cancer patient therapy. A proposal is presented to divide circadian rhythm and sleep disturbances into two major clusters with different management, however; with a common target to improve treatment efficiency and quality of life. Finally, a chrono-chemotherapy administration model is proposed in order to have less chemotherapy side effects.

Original languageEnglish (US)
Pages (from-to)632-642
Number of pages11
JournalCurrent Pharmaceutical Biotechnology
Volume14
Issue number6
StatePublished - 2013

Fingerprint

Circadian Rhythm
Drug Therapy
Neoplasms
Sleep
Quality of Life
Sleep Initiation and Maintenance Disorders
Defense Mechanisms
Melatonin
Enzymes
Therapeutics
Human Body
Catecholamines
Fatigue
Hydrocortisone
Down-Regulation
Hormones
Insulin
Gene Expression
Pharmaceutical Preparations
Genes

Keywords

  • Cancer
  • Chemotherapy
  • Chronomodulation
  • Circadian rhythm
  • Sleep disorders

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Biotechnology

Cite this

Zarogoulidis, P., Darwiche, K., Huang, H., Spyratos, D., Yarmus, L., Li, Q., ... Zarogoulidis, K. (2013). Time recall; future concept of chronomodulating chemotherapy for cancer. Current Pharmaceutical Biotechnology, 14(6), 632-642.

Time recall; future concept of chronomodulating chemotherapy for cancer. / Zarogoulidis, Paul; Darwiche, Kaid; Huang, Haidong; Spyratos, Dionysis; Yarmus, Lonny; Li, Qiang; Kakolyris, Stylianos; Syrigos, Konstantinos; Zarogoulidis, Konstantinos.

In: Current Pharmaceutical Biotechnology, Vol. 14, No. 6, 2013, p. 632-642.

Research output: Contribution to journalArticle

Zarogoulidis, P, Darwiche, K, Huang, H, Spyratos, D, Yarmus, L, Li, Q, Kakolyris, S, Syrigos, K & Zarogoulidis, K 2013, 'Time recall; future concept of chronomodulating chemotherapy for cancer', Current Pharmaceutical Biotechnology, vol. 14, no. 6, pp. 632-642.
Zarogoulidis P, Darwiche K, Huang H, Spyratos D, Yarmus L, Li Q et al. Time recall; future concept of chronomodulating chemotherapy for cancer. Current Pharmaceutical Biotechnology. 2013;14(6):632-642.
Zarogoulidis, Paul ; Darwiche, Kaid ; Huang, Haidong ; Spyratos, Dionysis ; Yarmus, Lonny ; Li, Qiang ; Kakolyris, Stylianos ; Syrigos, Konstantinos ; Zarogoulidis, Konstantinos. / Time recall; future concept of chronomodulating chemotherapy for cancer. In: Current Pharmaceutical Biotechnology. 2013 ; Vol. 14, No. 6. pp. 632-642.
@article{6696d315948c45acb1d408932bc967b6,
title = "Time recall; future concept of chronomodulating chemotherapy for cancer",
abstract = "The human metabolism is regulated by our internal clock; the circadian rhythm (24h-25h). There are several factors included in the regulatory pathway such as; genes (PER1-3), (CRY1-2), TIM hormones (cortisol, catecholamines, melatonin and insulin) drugs, enzymes, sleep disorders and diseases. Each one contributes in a different degree and in order to enhance the therapeutic result; we should include these factors into clusters instead of targeting each factor one by one. Malignances deregulate gene-protein expression/production, enzyme production, and in addition they induce fatigue, insomnia, stress and sleep disorders. All these factors finally contribute in minimizing the efficiency of chemotherapy treatment and quality of life. In addition, the circadian rhythm disruption induces tumor genesis, stress, and downregulates the defense and repair mechanisms of the human body. In the current mini review the underlying mechanism of the circadian rhythm is provided, along with the influence of sleep disturbances in cancer patient therapy. A proposal is presented to divide circadian rhythm and sleep disturbances into two major clusters with different management, however; with a common target to improve treatment efficiency and quality of life. Finally, a chrono-chemotherapy administration model is proposed in order to have less chemotherapy side effects.",
keywords = "Cancer, Chemotherapy, Chronomodulation, Circadian rhythm, Sleep disorders",
author = "Paul Zarogoulidis and Kaid Darwiche and Haidong Huang and Dionysis Spyratos and Lonny Yarmus and Qiang Li and Stylianos Kakolyris and Konstantinos Syrigos and Konstantinos Zarogoulidis",
year = "2013",
language = "English (US)",
volume = "14",
pages = "632--642",
journal = "Current Pharmaceutical Biotechnology",
issn = "1389-2010",
publisher = "Bentham Science Publishers B.V.",
number = "6",

}

TY - JOUR

T1 - Time recall; future concept of chronomodulating chemotherapy for cancer

AU - Zarogoulidis, Paul

AU - Darwiche, Kaid

AU - Huang, Haidong

AU - Spyratos, Dionysis

AU - Yarmus, Lonny

AU - Li, Qiang

AU - Kakolyris, Stylianos

AU - Syrigos, Konstantinos

AU - Zarogoulidis, Konstantinos

PY - 2013

Y1 - 2013

N2 - The human metabolism is regulated by our internal clock; the circadian rhythm (24h-25h). There are several factors included in the regulatory pathway such as; genes (PER1-3), (CRY1-2), TIM hormones (cortisol, catecholamines, melatonin and insulin) drugs, enzymes, sleep disorders and diseases. Each one contributes in a different degree and in order to enhance the therapeutic result; we should include these factors into clusters instead of targeting each factor one by one. Malignances deregulate gene-protein expression/production, enzyme production, and in addition they induce fatigue, insomnia, stress and sleep disorders. All these factors finally contribute in minimizing the efficiency of chemotherapy treatment and quality of life. In addition, the circadian rhythm disruption induces tumor genesis, stress, and downregulates the defense and repair mechanisms of the human body. In the current mini review the underlying mechanism of the circadian rhythm is provided, along with the influence of sleep disturbances in cancer patient therapy. A proposal is presented to divide circadian rhythm and sleep disturbances into two major clusters with different management, however; with a common target to improve treatment efficiency and quality of life. Finally, a chrono-chemotherapy administration model is proposed in order to have less chemotherapy side effects.

AB - The human metabolism is regulated by our internal clock; the circadian rhythm (24h-25h). There are several factors included in the regulatory pathway such as; genes (PER1-3), (CRY1-2), TIM hormones (cortisol, catecholamines, melatonin and insulin) drugs, enzymes, sleep disorders and diseases. Each one contributes in a different degree and in order to enhance the therapeutic result; we should include these factors into clusters instead of targeting each factor one by one. Malignances deregulate gene-protein expression/production, enzyme production, and in addition they induce fatigue, insomnia, stress and sleep disorders. All these factors finally contribute in minimizing the efficiency of chemotherapy treatment and quality of life. In addition, the circadian rhythm disruption induces tumor genesis, stress, and downregulates the defense and repair mechanisms of the human body. In the current mini review the underlying mechanism of the circadian rhythm is provided, along with the influence of sleep disturbances in cancer patient therapy. A proposal is presented to divide circadian rhythm and sleep disturbances into two major clusters with different management, however; with a common target to improve treatment efficiency and quality of life. Finally, a chrono-chemotherapy administration model is proposed in order to have less chemotherapy side effects.

KW - Cancer

KW - Chemotherapy

KW - Chronomodulation

KW - Circadian rhythm

KW - Sleep disorders

UR - http://www.scopus.com/inward/record.url?scp=84888217472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888217472&partnerID=8YFLogxK

M3 - Article

C2 - 24180308

AN - SCOPUS:84888217472

VL - 14

SP - 632

EP - 642

JO - Current Pharmaceutical Biotechnology

JF - Current Pharmaceutical Biotechnology

SN - 1389-2010

IS - 6

ER -